- Home
- BMRA vs ONVO Comparison
BMRA vs ONVO Comparison
Compare BMRA & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- ONVO
- Stock Information
- Founded
- BMRA 1971
- ONVO 2007
- Country
- BMRA United States
- ONVO United States
- Employees
- BMRA N/A
- ONVO N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BMRA Health Care
- ONVO Health Care
- Exchange
- BMRA Nasdaq
- ONVO Nasdaq
- Market Cap
- BMRA 7.4M
- ONVO 8.6M
- IPO Year
- BMRA N/A
- ONVO N/A
- Fundamental
- Price
- BMRA $0.35
- ONVO $0.54
- Analyst Decision
- BMRA
- ONVO
- Analyst Count
- BMRA 0
- ONVO 0
- Target Price
- BMRA N/A
- ONVO N/A
- AVG Volume (30 Days)
- BMRA 994.2K
- ONVO 49.1K
- Earning Date
- BMRA 10-11-2024
- ONVO 09-17-2024
- Dividend Yield
- BMRA N/A
- ONVO N/A
- EPS Growth
- BMRA N/A
- ONVO N/A
- EPS
- BMRA N/A
- ONVO N/A
- Revenue
- BMRA $5,415,000.00
- ONVO $73,000.00
- Revenue This Year
- BMRA N/A
- ONVO $59.08
- Revenue Next Year
- BMRA N/A
- ONVO $18.24
- P/E Ratio
- BMRA N/A
- ONVO N/A
- Revenue Growth
- BMRA 1.42
- ONVO N/A
- 52 Week Low
- BMRA $0.24
- ONVO $0.50
- 52 Week High
- BMRA $2.13
- ONVO $2.05
- Technical
- Relative Strength Index (RSI)
- BMRA 41.31
- ONVO 38.37
- Support Level
- BMRA $0.43
- ONVO $0.52
- Resistance Level
- BMRA $0.47
- ONVO $0.61
- Average True Range (ATR)
- BMRA 0.06
- ONVO 0.04
- MACD
- BMRA -0.00
- ONVO -0.00
- Stochastic Oscillator
- BMRA 14.21
- ONVO 19.56
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.